Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills]) - Global Forecasts to 2029
Redding, California, June 14, 2022 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills]) - Global Forecasts to 2029’, published by Meticulous Research®, the pharmaceutical processing equipment market is projected to grow at a CAGR of 4.2% during the forecast period 2022–2029 to reach $12.85 Billion by 2029.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5296
The pharmaceutical industry includes a set of processes like manufacturing, extraction, processing, and packaging of drugs to treat or cure diseases. Pharmaceutical manufacturing comprises two processes, primary processing, which includes the production of active ingredients & drugs, and secondary processing, which includes the conversion of active products into suitable administration dosages. The processing equipment included in the scope is divided based on the mode of delivery.
The growth of the pharmaceutical processing market is attributed to the increasing regulatory approvals of pharmaceutical products, increasing production capacities, the emergence of flexible and continuous manufacturing, and rapid expansion of the pharmaceutical market. Increasing outsourcing of manufacturing capabilities also drives this market. Emerging pharmaceutical manufacturing hotspots in developing countries and a growing clinical pipeline offer opportunities for the growth of the pharmaceutical processing equipment market.
Impact of COVID-19 on the Pharmaceutical Processing Equipment Market
The COVID-19 pandemic has affected the healthcare industry globally. The pandemic has increased the demand for vaccines and therapies, due to which various pharmaceutical manufacturers have expanded their manufacturing facilities. The capacity expansion plans by the manufacturers are expected to improve the demand for pharmaceutical processing equipment. The pandemic led to a temporary disruption in the supply chain due to the nationwide lockdowns imposed in various countries. The lockdowns led to temporary shutdowns of local manufacturing plants, due to which the supply of APIs and finished dosages was largely affected.
Due to supply chain disruption, several countries decided to increase the domestic manufacturing of therapeutics to decrease the dependence on imports. Such initiatives by the governments in various countries are expected to positively impact the growth of the pharmaceutical processing equipment market.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5296
The global pharmaceutical processing equipment market is segmented by mode of delivery (oral [oral solid dosages {blending equipment, fluidized bed machine, milling equipment, compression/press equipment, capsule making equipment, capsule filling equipment, and other processing equipment}, oral liquid dosages {sugar charging/transfer systems, preparation vessels, melting vessels, and storage tanks, stirrers and homogenizers, filtration units, and other processing equipment}], parenteral [mixing equipment, preparation tank, and other containers, process systems (SVP, LVP), filtration units, sterilization tunnels, clean-in-place (CIP) and steam-in-place (SIP) system, aseptic inspection systems, and other processing equipment], topicals [planetary and homogenizer mixer, preparation vessels, reactors, and storage tanks, colloid mills, agitator–stirrer, and other processing equipment]), and geography.
Based on mode of drug delivery, in 2022, oral formulations segment is estimated to generate the largest proportion of revenue in the pharmaceutical processing equipment market. The large revenue share of this mode is mainly to its ease in consumption, convenience, safety, and cost-effectiveness. Furthermore, patients’ compliance is higher with this mode than with other delivery modes. The oral dosage forms also offer ease in large-scale manufacturing. Thus, based on these factors, the preference for oral formulations is likely to continue to increase during the forecast period.
However, the parenteral formulation segment is estimated to grow with the highest CAGR over the forecast period. Parenteral formulations are either administered as infusion or injection. Parenteral preparations include powders, gels, suspensions, and solutions. High preference for the parenteral formulation, in case of drugs that are poorly absorbed, ineffective, or inactive if given orally, and provision of immediate onset of action are the factors driving the growth of this market. Physicians prefer the parenteral route of administration for unconscious patients or patients with a non-functional gastrointestinal tract. Bypassing the gastrointestinal tract provides immediate physiologic response and complete systemic circulation. Thus, if oral administration is not possible, parenteral formulation drives the demand for processing equipment for parenteral formulations.
Based on geography, in 2022, North America is estimated to account for the largest share of the market. Reshoring of pharmaceutical manufacturing in the U.S., expansion of manufacturing facilities, and agreements between pharmaceutical companies and CMOs to increase the availability of pharmaceuticals are the key factors contributing to the largest share in North America. Additionally, an increase in the government funding to develop COVID-19-related-therapies is also driving the demand for innovative technologies in pharmaceutical processing.
Quick Buy – “Pharmaceutical Processing Equipment Market by Mode of Delivery (Oral [OSDs {Coating, Milling}, Oral Liquid Dosages {Filtration Units}], Parenterals [SIP, CIP, Process Systems], Topicals [Agitators, Homogenizers, Colloid Mills]) - Global Forecasts to 2029” Research Report: https://www.meticulousresearch.com/Checkout/23054852
However, the Asia-Pacific region is projected to grow lucratively over the forecast period. The key factors attributing to this are emerging pharmaceutical hotspots in this region and government initiatives to incentivize domestic production. Furthermore, the expansion of manufacturing facilities in pharmaceutical companies is also attributed to the market growth.
The report also includes an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past three years (2019–2022). The global pharmaceutical processing equipment market has witnessed product launches, collaborations, partnerships, agreements, acquisitions, and expansions in the last couple of years.
Some of the key players operating in the global pharmaceutical processing equipment market are ACG (India), Cadmach Machinery Company Private Limited (India), GEA GROUP (Germany), Sainty Co. (China), Syntegon Technology GmbH (Germany), Freund Corporation (Japan), ACIC Pharmaceuticals Inc. (Canada), Bausch+Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG (Germany), Fette Compacting GmbH (Germany), IDEX Corporation (U.S.), Kevin Process Technologies Private Limited (India), KIKUSUI SEISAKUSHO LTD. (Japan), KORSCH AG (Germany), MAQUINARIA INDUSTRIAL DARA, SL (Spain), and Marchesini Group S.p.A. (Italy).
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/pharmaceutical-processing-equipment-market-5296
Pharmaceutical Processing Equipment Market, by Mode of Delivery
Other Processing Equipment (Other processing equipment for oral solid dosages majorly includes inspection machines, dust extractors, and polishing machines)
Preparation Vessels, Melting Vessels, and Storage Tanks
Others (Other processing equipment for oral liquid dosages majorly includes transfer pumps and interconnect pipelines)
Mixing Equipment, Preparation Tank, and Other Containers
Clean-in-Place (CIP) and Steam-in-Place (SIP) System
Other Processing Equipment (Other processing equipment for parenteral formulations majorly include debagging machine, nest unpackers, tray unpackers, tray loading, buffering, and barrier systems)
Preparation Vessels, Reactors, and Storage Tanks
Other Processing Equipment (Other processing equipment for topical formulations majorly include milling equipment and sifters)
Other Formulations (Other formulations majorly include trans-mucosal and inhalation drugs)
Pharmaceutical Processing Equipment Market, by Geography
Middle East & Africa (MEA)
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5296
Pharmaceutical Contract Development & Manufacturing Market by Service {Manufacturing [API, FDF (Parenteral, Injectable, Tablet, Capsule, Oral Liquid)], Drug Development, Biologics Manufacturing}, End User [Large Pharma, Generic] - Global Forecast to 2029
https://www.meticulousresearch.com/product/pharmaceutical-contract-development-and-manufacturing-market-5171
Pharmaceutical Automation Market by Component (Plant-level Controls, Enterprise-level Controls, Plant Instrumentation), Mode of Automation (Semi-automatic, Fully-automatic), End User, and Geography - Global Forecast to 2029
https://www.meticulousresearch.com/product/pharmaceutical-automation-market-5280
Biopharmaceutical Processing Equipment and Consumables Market by Product Type {Filtration, Chromatography [Consumables, Equipment], Disposable Bioreactors, Cell Culture Media, Shakers, Services), Application (Vaccine, mAb, R&D), and End User- Forecast to 2029
https://www.meticulousresearch.com/product/biopharmaceutical-processing-equipment-consumables-market-4200
Pharmaceutical Processing and Packaging Equipment Market by Mode of Delivery (Oral, Parenteral, Topical), Secondary Packaging (Cartoning, Labelling, Serialization), and End-of-Line Packaging (Palletizing, Case Packaging) - Global Forecasts to 2028
https://www.meticulousresearch.com/product/pharmaceutical-processing-and-packaging-equipment-market-5021
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
Contact: Mr. Khushal Bombe Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- sales@meticulousresearch.com Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Content Source: https://www.meticulousresearch.com/pressrelease/520/pharmaceutical-processing-equipment-market-2029
Buffett swapped out Wells Fargo and Goldman Sachs for a beaten-down bank.
When Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett speaks, Wall Street and investors wisely pay close attention. While riding Buffett's coattails has been a moneymaking strategy for decades, it's equally important to take note of the stocks that the world's most successful investor and his investing team are selling or avoiding. Thus far in 2022, Warren Buffett has overseen the aggressive selling of the following five stocks.
AMD and Nvidia have been swallowed up in the bear market, with each stock declining at least 50%. Here's how to trade them now.
Already, very early signs of slowing demand and inflation are cropping up. If the economy averts all-out disaster, then stabilizing or declining rates would spur a market rebound.
It's no secret that Warren Buffett is one of the best investors alive, delivering investors returns of 20% compounded annually since becoming chief executive officer of Berkshire Hathaway in 1965. Numerous factors can explain Buffett's success, and an important one is his love of dividend stocks. Dividend stocks are a great source of returns in the market and, according to Fidelity, have accounted for 40% of the S&P 500's total returns since 1930.
Elon Musk was sued for $258 billion on Thursday by a Dogecoin investor who accused him of running a pyramid scheme to support the cryptocurrency. In a complaint filed in federal court in Manhattan, plaintiff Keith Johnson accused Musk, electric car company Tesla Inc and space tourism company SpaceX of racketeering for touting Dogecoin and driving up its price, only to then let the price tumble.
Remember TINA? She’s the one everyone was talking about for the past few years, when it came to buying stocks. ‘There is no alternative,’ they said – pointing out that the near-zero interest rate policy has pushed bond yields down to nothing, and that the housing crisis of 2008 had left investors wary of the real estate market – and stocks were the highest returning game in town. Not anymore. The Federal Reserve has just cracked the whip on rate hikes, implementing a 0.75% increase to the benchm
Warren Buffett is one of the all-time greats when it comes to finding winning investments in challenging markets. Through recessions, periods of high inflation, wars, pandemics, and other tough market conditions, the Oracle of Omaha has guided his conglomerate Berkshire Hathaway -- and its impressive stock portfolio -- to market-crushing performances, and inspired generations of analysts and investors along the way. With a nod to Buffett's incredible track record, three Motley Fool contributors have singled out a few stocks in the Berkshire Hathaway portfolio that they think look like great buys in this wild market.
Bank stocks are dirt-cheap right now, and Citi in particular looks like a bargain. Watch the Fed’s stress-test results—and Warren Buffett’s purchases—to see what might be in store.
Yahoo Finance's Alexis Keenan explains a lawsuit levied against Tesla, SpaceX, and Elon Musk alleging dogecoin scheme.
Data shows new electric vehicle (EV) purchases jumped in Q1, and many industry watchers speculate that high gas prices are driving this behavior. A new study from Autolist, an online car shopping platform, shows that gas prices actually are not driving more EV consumer sentiment.
This year’s plunge in the stock market, unprecedented crash in the bond market, and surging inflation threaten new retirees in ways not seen before, he says. “The Jan. 1, 2022 retiree is retiring under conditions which have no certain precedent in the historical records I have used for my research,” Bengen tells MarketWatch. If the recent surge in inflation isn’t brought under control, he says, “we may witness history being made, and the first decline in the ‘safe’ withdrawal rate in more than 50 years.”
Over the past year or two, investors have seen a number of popular stocks carry out well-publicized stock splits. For instance, Amazon completed a 20-for-1 stock split on June 6, Shopify is planning a 10-for-1 stock split on June 28, and Alphabet's (NASDAQ: GOOG)(NASDAQ: GOOGL) 20-for-1 stock split is scheduled to occur on July 15. Historically, stock splits have been a sign of management's confidence in the company's ability to keep growing and investors become bullish as well.
Hennion & Walsh CIO Kevin Mahn and Threadneedle Ventures Founder Ann Berry join Yahoo Finance Live to talk about this week's volatile market losses, which sectors investors should look into to ford recession concerns, blockchain technology across industries, and recession risks amid rising inflation and the Fed's interest rate hikes.
Maybe skip the fill-up in the Nordic region of the world…
Don't let its share price movement fool you. This e-commerce stock is poised to bounce back in the long run.
One of Costco Wholesale's most popular products is turning into a headache for the warehouse retailer, and it's one the company doesn't even make any money on. Costco willingly loses money on the chickens to maintain customer loyalty and draw visits that result in sales of other profitable products. Concerned with the animal welfare costs of producing such cheap poultry, two shareholders in Washington state recently filed a lawsuit accusing Costco of "illegal neglect and abandonment" when it comes to how it raises poultry at its new Nebraska facility.
Would you be interested in an asset class that produces long-term returns that are nearly as good as the stock market but is as uncorrelated with the stock market as bonds are? Residential real estate, in contrast, not only resisted stocks’ decline but actually gained in value.
(Bloomberg) -- Bitcoin fell below $20,000 for the first time since December 2020 as evidence of deepening stress within the crypto industry keeps piling up against a backdrop of monetary tightening. Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US
These real estate investment trusts offer yields that are well over double that of the broader market, long dividend increase streaks, and favorable growth and dividend outlooks.